Solid tumours

CAR-T therapy
#Cancer research #CAR-T #Cell therapy #CRISPR #CRISPR-Cas9 #Gene editing #Oncology #Solid tumours

Double knockout strategy could boost CAR-T in solid tumours

A new approach that delivers a ‘one-two punch’ to help T cells attack solid tumours is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania. The findings showed that targeting two regulators that control gene functions… Read More

#Cancer Research #News #Trending News

Medical laboratory
#Antibody drug conjugate (ADC) #Bio-Thera Solutions #Cancer research #Oncology #Phase I trial #Solid tumours

Company launches ADC Phase I trial in solid tumours

Dosing has begun in a Phase I clinical study evaluating BAT8008, an antibody-drug conjugate (ADC) that targets Trop2.   Key objectives of the study are to determine the maximum tolerated dose (MTD), recommended Phase II dose (RP2D), and to evaluate the pharmacokinetics and preliminary efficacy in patients with… Read More

#Cancer Research #News